-+ 0.00%
-+ 0.00%
-+ 0.00%

Organon Announces Its Audit Committee's Review Of 2025 Purchases Of Biosimilars Found No Evidence Of Improper Conduct

Benzinga·02/20/2026 12:39:50
Listen to the news

SEC.